I had really hoped the Viraleze trial results and long-awaited DEP-Docetaxel monotherapy results would have been released prior to the AGM.
The fact that both are now going to be released in XMAS silly season (DEP-Docetaxel results could even slide into 2024) is a concern and is a bit smelly IMO.
Look at the Buy side depth. It looks horrible. Whilst the ‘heavy’ selling has somewhat dried up, the share price appears ready to potentially roll over lower.
Is it possible SPL could be getting to 10 cents for XMAS?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.27M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.0¢ | $30.12K | 241.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48116 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 450307 | 4 |
View Market Depth
| Last trade - 15.30pm 17/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |